Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Multi-drug resistant tuberculosis (MDR-TB) is a critical global public health problem. WHAT IS ADDED BY THIS REPORT? Sputum cultures and lung images show a strong association with treatment outcomes, serving as a multi-dimensional approach to identify MDR-TB p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shunxian, Qiu, Lei, Wu, Dingzhong, Zhang, Shaoyan, Pan, Chenhui, Li, Cui, Xiao, Heping, Huang, Fuli, Wang, Hua, Jiang, Feng, Zhang, Huiyong, Zheng, Peiyong, Lu, Zhenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Preplanned Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681604/
https://www.ncbi.nlm.nih.gov/pubmed/36426288
http://dx.doi.org/10.46234/ccdcw2022.187
_version_ 1784834652144402432
author Zhang, Shunxian
Qiu, Lei
Wu, Dingzhong
Zhang, Shaoyan
Pan, Chenhui
Li, Cui
Xiao, Heping
Huang, Fuli
Wang, Hua
Jiang, Feng
Zhang, Huiyong
Zheng, Peiyong
Lu, Zhenhui
author_facet Zhang, Shunxian
Qiu, Lei
Wu, Dingzhong
Zhang, Shaoyan
Pan, Chenhui
Li, Cui
Xiao, Heping
Huang, Fuli
Wang, Hua
Jiang, Feng
Zhang, Huiyong
Zheng, Peiyong
Lu, Zhenhui
author_sort Zhang, Shunxian
collection PubMed
description WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Multi-drug resistant tuberculosis (MDR-TB) is a critical global public health problem. WHAT IS ADDED BY THIS REPORT? Sputum cultures and lung images show a strong association with treatment outcomes, serving as a multi-dimensional approach to identify MDR-TB patients with poor outcomes. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The results imply that funds and policy investments should be increased by early monitoring of MDR-TB patients, especially regarding imaging and sputum bacterium. By informing physicians on changes to the therapeutic schedule, treatment outcomes can be improved.
format Online
Article
Text
id pubmed-9681604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-96816042022-11-23 Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020 Zhang, Shunxian Qiu, Lei Wu, Dingzhong Zhang, Shaoyan Pan, Chenhui Li, Cui Xiao, Heping Huang, Fuli Wang, Hua Jiang, Feng Zhang, Huiyong Zheng, Peiyong Lu, Zhenhui China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? Multi-drug resistant tuberculosis (MDR-TB) is a critical global public health problem. WHAT IS ADDED BY THIS REPORT? Sputum cultures and lung images show a strong association with treatment outcomes, serving as a multi-dimensional approach to identify MDR-TB patients with poor outcomes. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? The results imply that funds and policy investments should be increased by early monitoring of MDR-TB patients, especially regarding imaging and sputum bacterium. By informing physicians on changes to the therapeutic schedule, treatment outcomes can be improved. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-10-14 /pmc/articles/PMC9681604/ /pubmed/36426288 http://dx.doi.org/10.46234/ccdcw2022.187 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Zhang, Shunxian
Qiu, Lei
Wu, Dingzhong
Zhang, Shaoyan
Pan, Chenhui
Li, Cui
Xiao, Heping
Huang, Fuli
Wang, Hua
Jiang, Feng
Zhang, Huiyong
Zheng, Peiyong
Lu, Zhenhui
Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
title Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
title_full Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
title_fullStr Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
title_full_unstemmed Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
title_short Predictors for Treatment Outcomes in Patients with Multi-drug Resistant Tuberculosis — China, 2018–2020
title_sort predictors for treatment outcomes in patients with multi-drug resistant tuberculosis — china, 2018–2020
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681604/
https://www.ncbi.nlm.nih.gov/pubmed/36426288
http://dx.doi.org/10.46234/ccdcw2022.187
work_keys_str_mv AT zhangshunxian predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT qiulei predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT wudingzhong predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT zhangshaoyan predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT panchenhui predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT licui predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT xiaoheping predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT huangfuli predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT wanghua predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT jiangfeng predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT zhanghuiyong predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT zhengpeiyong predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020
AT luzhenhui predictorsfortreatmentoutcomesinpatientswithmultidrugresistanttuberculosischina20182020

Ejemplares similares